NURE | USRT | NURE / USRT | |
Gain YTD | -4.049 | 1.611 | -251% |
Net Assets | 35.9M | 3.01B | 1% |
Total Expense Ratio | 0.35 | 0.08 | 438% |
Turnover | 29.00 | 7.00 | 414% |
Yield | 4.21 | 3.00 | 140% |
Fund Existence | 9 years | 18 years | - |
NURE | USRT | |
---|---|---|
RSI ODDS (%) | N/A | N/A |
Stochastic ODDS (%) | 3 days ago84% | 3 days ago77% |
Momentum ODDS (%) | 3 days ago76% | 3 days ago86% |
MACD ODDS (%) | 3 days ago78% | 3 days ago90% |
TrendWeek ODDS (%) | 3 days ago87% | 3 days ago87% |
TrendMonth ODDS (%) | 3 days ago86% | 3 days ago87% |
Advances ODDS (%) | 25 days ago84% | 5 days ago86% |
Declines ODDS (%) | 3 days ago84% | 3 days ago83% |
BollingerBands ODDS (%) | 3 days ago83% | 3 days ago82% |
Aroon ODDS (%) | N/A | 3 days ago84% |
A.I.dvisor indicates that over the last year, NURE has been closely correlated with CPT. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if NURE jumps, then CPT could also see price increases.
Ticker / NAME | Correlation To NURE | 1D Price Change % | ||
---|---|---|---|---|
NURE | 100% | -0.03% | ||
CPT - NURE | 80% Closely correlated | -0.05% | ||
UDR - NURE | 80% Closely correlated | -0.25% | ||
IRT - NURE | 79% Closely correlated | -0.17% | ||
AVB - NURE | 79% Closely correlated | +0.08% | ||
EQR - NURE | 78% Closely correlated | -0.41% | ||
More |
A.I.dvisor indicates that over the last year, USRT has been closely correlated with ARE. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if USRT jumps, then ARE could also see price increases.
Ticker / NAME | Correlation To USRT | 1D Price Change % | ||
---|---|---|---|---|
USRT | 100% | -0.10% | ||
ARE - USRT | 85% Closely correlated | +0.17% | ||
PLD - USRT | 85% Closely correlated | +0.52% | ||
STAG - USRT | 84% Closely correlated | +0.22% | ||
BRX - USRT | 84% Closely correlated | -0.62% | ||
KIM - USRT | 83% Closely correlated | -0.91% | ||
More |